DRAP Draft Guidance on Clinical Research: Application Process
The new article highlights the critical points related to the application process, outlining the key steps to be taken when applying for approval in a clinical investigation.
The new article highlights the critical points related to the application process, outlining the key steps to be taken when applying for approval in a clinical investigation.
The present article outlines the key points related to the existing legal framework and explains the basics of the approach to be followed.
The Directorate General of Pharmaceutical Affairs & Drug Control (DGPA & DC), the regulating authority in the sphere of healthcare products of the Sultanate of Oman, has published draft guidance dedicated to regulatory requirements for the registration of...
The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has published a guidance document dedicated to design control in the context of medical devices. Among other matters, the document addresses aspects...
The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has published a guidance document dedicated to the content of premarket submissions for software contained in medical devices. The document provides...